{"id":"prebiotin","rwe":[],"tags":[],"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Prebiotin","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:31:58.103337+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:32:03.365768+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Prebiotin","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:32:03.740926+00:00"}},"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"_scrapedAt":"2026-03-28T00:02:11.832Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:32:05.822142+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT05527210","phase":"NA","title":"Prebiotic Treatment in People With Schizophrenia","status":"RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2023-01-25","conditions":"Schizophrenia, Schizoaffective Disorder","enrollment":60},{"nctId":"NCT04038541","phase":"NA","title":"Prebiotic vs Probiotic in Multiple Sclerosis","status":"COMPLETED","sponsor":"Columbia University","startDate":"2020-03-11","conditions":"Multiple Sclerosis, Clinically Isolated Syndrome (CIS)","enrollment":37},{"nctId":"NCT03950336","phase":"NA","title":"Prebiotics and Diet to Reduce \"Leaky\" Gut in First Degree Relatives of Crohn's Disease Patients","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2020-02-04","conditions":"Healthy First Degree Relatives of Crohn's Disease Patients","enrollment":33},{"nctId":"NCT04060212","phase":"NA","title":"Mercury Metabolism by Bacteria in Humans","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2019-10-01","conditions":"Mercury--Toxicology","enrollment":36},{"nctId":"NCT03617783","phase":"PHASE4","title":"Prebiotic Treatment in People With Schizophrenia - Pilot Study","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2019-07-18","conditions":"Schizophrenia, Schizoaffective Disorder","enrollment":26},{"nctId":"NCT04498455","phase":"PHASE4","title":"Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency","status":"COMPLETED","sponsor":"Baylor University","startDate":"2018-09-30","conditions":"Weight Gain Trajectory, Metabolic Syndrome","enrollment":11}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":2,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Prebiotin","genericName":"Prebiotin","companyName":"University of Maryland, Baltimore","companyId":"university-of-maryland-baltimore","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":2,"withResults":1},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:32:05.822142+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}